Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 Feb 23
Testing: Time to Put Patient Safety First.
Related Questions
For either patients in general or for patients who will receive regimens with well-described toxicities such as irinotecan/UGT1A1.
If so, do you requ...
New comment by Medical Oncologist at Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center ( January 13, 2025)
It is worth noting that the great majority of fatal toxicities related to DPD deficiency occur in patients with a single deleterious DPYD gene mutation; "double DPYD mutations...